Literature DB >> 8993396

Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1, and other members of their new family of G protein-linked receptors: structure-function relationship with special reference to the human VIP-1 receptor.

M Laburthe1, A Couvineau, P Gaudin, J J Maoret, C Rouyer-Fessard, P Nicole.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8993396     DOI： 10.1111/j.1749-6632.1996.tb17476.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  20 in total

1.  (N-stearyl, norleucine17)VIPhybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist.

Authors:  Terry W Moody; Robert T Jensen; Mati Fridkin; Illana Gozes
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

2.  Constitutive activation of tethered-peptide/corticotropin-releasing factor receptor chimeras.

Authors:  S M Nielsen; L Z Nielsen; S A Hjorth; M H Perrin; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

3.  Differential determinants for coupling of distinct G proteins with the class B secretin receptor.

Authors:  Gene L Garcia; Maoqing Dong; Laurence J Miller
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

4.  Combined administration of secretin and oxytocin inhibits chronic colitis and associated activation of forebrain neurons.

Authors:  Martha G Welch; Muhammad Anwar; Christine Y Chang; Kara J Gross; David A Ruggiero; Hadassah Tamir; Michael D Gershon
Journal:  Neurogastroenterol Motil       Date:  2010-03-04       Impact factor: 3.598

5.  Role of second extracellular loop in the function of human vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide receptor 1 (hVPAC1R).

Authors:  S M Knudsen; J W Tams; J Fahrenkrug
Journal:  J Mol Neurosci       Date:  2000-06       Impact factor: 3.444

Review 6.  Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Authors:  Bronwen Martin; Rakel Lopez de Maturana; Randall Brenneman; Tom Walent; Mark P Mattson; Stuart Maudsley
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 7.  Neuropeptides of the pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide/growth hormone-releasing hormone/secretin family in testis.

Authors:  Min Li; Akira Arimura
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

8.  Discovery of growth hormone-releasing hormones and receptors in nonmammalian vertebrates.

Authors:  Leo T O Lee; Francis K Y Siu; Janice K V Tam; Ivy T Y Lau; Anderson O L Wong; Marie C M Lin; Hubert Vaudry; Billy K C Chow
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-05       Impact factor: 11.205

Review 9.  Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications.

Authors:  Satomi Onoue; Shingen Misaka; Shizuo Yamada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-03       Impact factor: 3.000

10.  G protein-coupled receptor genes in the FANTOM2 database.

Authors:  Yuka Kawasawa; Louise M McKenzie; David P Hill; Hidemasa Bono; Masashi Yanagisawa
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.